期刊文献+

醋酸泼尼松联合环磷酰胺治疗甲亢浸润性突眼的疗效观察 被引量:1

Efficacy of Prednisone Plus Cyclophosphamide in Treatment of Infiltrative Exophthalmos of Hyperthyroidism
下载PDF
导出
摘要 目的探讨醋酸泼尼松联合环磷酰胺治疗甲亢浸润性突眼临床应用效果。方法对照组给予常规临床治疗,研究组在常规治疗基础上加用醋酸泼尼松联合环磷酰胺,记录两组甲亢浸润性突眼患者临床疗效。结果研究组甲亢浸润性突眼患者经治疗后获得高达90.00%的临床治疗总有效率,对照组仅获得75.00%的临床治疗总有效率(P<0.05)。结论经常规治疗联合醋酸泼尼松、环磷酰胺后甲亢浸润性突眼患者临床疗效获得显著提高,其生活质量得到有利保障。 Objective Discussion of prednisone and cyclophosphamide to treat hyperthyroidism exophthalmos invasive clinical effect.Methods The control group received routine clinical treatment, research group on the basis of conventional therapy plus prednisone plus cyclophosphamide, recording the clinical efficacy of the two groups of patients with hyperthyroidism infiltrative exophthalmos.Results Study group after infiltrating exophthalmos hyperthyroidism treated patients receive up to 90.00% of the total efifciency of the clinical treatment, the control group received only 75.00% of the total efficiency of the clinical treatment (P &lt;0.05).Conclusion By conventional therapy combined with prednisone, clinical efifcacy in patients with hyperthyroidism inifltrative exophthalmos obtained after cyclophosphamide significantly improved, their quality of life has been a strong guarantee.
作者 王玉风
出处 《中国继续医学教育》 2015年第30期157-158,共2页 China Continuing Medical Education
关键词 甲亢浸润性突眼 醋酸泼尼松 环磷酰胺 临床疗效 The clinical efifcacy Inifltrative exophthalmos hyperthyroidism Prednisone Cyclophosphamide
  • 相关文献

参考文献3

二级参考文献16

  • 1朱盈援.小剂量强的松治疗男性甲亢浸润性突眼31例疗效分析[J].现代医药卫生,2007,23(7):965-966. 被引量:11
  • 2BARTLEY G B, GORMAN C V. Diagnostic criteria for Graves' ophthalmopathy[ J]. Am J Ophthalmol, 1995, 119 ( 6 ) : 792 - 795.
  • 3WERNER S C. Modification of the classification of the eye chan- ges of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association [ J ]. J Clin Endocrinol Metab, 1977, 44( 1 ) : 203 - 204.
  • 4HENRY M, KRONENBERG M D. Williams textbooks of endocri- nology[M], llth ed. Phidadelphia: Saunders Co, 2008:333 - 375.
  • 5MOURITS M P, PRUMMEL M F, WIERSINGA W M, et al. Clinical Activity Score as aguide in the management of patients with Graves' ophthalmopathy [ J ]. Clin Endocrinol (Oxf) , 1997, 47(1):9-14.
  • 6ARDLEY M, MCCORQUODALE T, LAHOOTI H, et al. Eye findings and immunological markers in probands and their euthy- mid relatives from a single family with muhiple cases of thyroid au- toimmunity[ J]. Thyroid, 2012, 5 (1):4.
  • 7TEKTONIDOU M G, ANAPLIOTOU M, VALCHOYIANNO- PLOULOS P, et al. Presence of systemic autonimmun disorders in patients with in systemic autonimmun thyroid diseases [ J ]. Ann Rheum Dis, 2004, 63(9) : 1159 - 1161.
  • 8白耀.甲状腺功能亢进症[M]∥史轶蘩.协和内分泌和代谢学.北京:科学出版社,1999:1019-1051.
  • 9COLE M, MITCHELL S, PAISEY R, et al. Recognising and trea- ting thyroid - associated ophthalmopathy[ J]. Practitioner, 1995, 239(1549) : 261 -263.
  • 10KRASSAS G E, HEUFELDER A E. Immunosuppressive therapy in patients with thyroid eye disease: an overview of current con- cepts[J]. Eur J Endocrinol, 2001, 144(4) : 311 -318.

共引文献11

同被引文献11

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部